Niraparib

CAS 1038915-60-4

Overview

Niraparib, sold under the brand name Zejula, is an anti-cancer medication used for the treatment of epithelial ovarian, fallopian tube, or primary peritoneal cancer. It is taken by mouth. It is a PARP inhibitor

Anant Labs manufacture and furnish high quality Niraparib impurities for global markets. Our Niraparib EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

In Stock

Niraparib

CAS 1038915-60-4In Stock

Technical Data

CAS1038915-60-4

Mol. FormulaC₁₉H₂₀N₄O

Mol. Weight320.396 g/mol

IUPAC2-[4-[(3S)-piperidin-3-yl]phenyl]indazole-7-carboxamide

SMILESC1C[C@H](CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N

InChIInChI=1S/C19H20N4O/c20-19(24)17-5-1-3-15-12-23(22-18(15)17)16-8-6-13(7-9-16)14-4-2-10-21-11-14/h1,3,5-9,12,14,21H,2,4,10-11H2,(H2,20,24)/t14-/m1/s1

InChI KeyPCHKPVIQAHNQLW-CQSZACIVSA-N

Note: We are upgrading our system, Cat No will change.

Synonyms

Niraparib1038915-60-4MK48272-{4-[(3s)-piperidin-3-yl]phenyl}-2h-indazole-7-carboxamide2-[4-[(3S)-piperidin-3-yl]phenyl]indazole-7-carboxamideHMC2H89N35ZL-2306JNJ-64091742CHEBI:176844DTXSID50146129